Conestoga Capital Advisors, an asset management company, released its third-quarter 2025 investor letter. A copy of the ...

IDEXX Laboratories, Inc. IDXX is set to release third-quarter 2025 results on Nov. 3, before the opening bell. In the last ...

IDEXX Laboratories has recently seen its Fair Value Estimate decrease from $695.09 to $679.92. This reflects a modest downward adjustment in the company’s projected value. This change comes as revenue ...

Stifel analyst Jonathan D. Block reiterated a Hold rating on IDEXX Laboratories, Inc. (NASDAQ:IDXX), lowering the price target to $500 from $525. IDEXX is capturing market share across multiple ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Idexx ...

How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors and ...

IDEXX Laboratories, a healthcare supplier specializing in veterinary health diagnostics and research, is a potential high-performing compounder due to its wide-moat business model, anti-cyclical ...

Seilern Investment Management Ltd disclosed the sale of 70,900 shares of IDEXX Laboratories for the period ended September 30, 2025, an estimated $43.03 million trade based on the average price for Q3 ...

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in the Stifel Jaws & Paws Conference on Wednesday, May 31, ...

Pet healthcare is a large and growing global market. Veterinarians are rapidly adopting in-office diagnostic testing tools. Increased testing is the foundation of Idexx's attractive recurring-revenue ...